WEBULL
WebtradeDownload

Is Ensign Group (ENSG) Undervalued After Reaffirming Its Quarterly Dividend?

Simply Wall St · 1d ago

Ensign Group (ENSG) has affirmed a quarterly cash dividend of $0.065 per share, payable on or before October 31, 2026, to shareholders of record as of September 30, 2026.

Ensign Group’s US$175.46 share price has eased slightly in recent weeks, with the 30 day share price return down 2.18% after a softer 7 day move. However, a 90 day share price gain of 5.86% and a 3 year total shareholder return of 90.52% point to momentum that has built over a longer horizon.

Scan beyond Ensign Group and compare this dividend move with other healthcare operators on our hand picked screener of list of solid balance sheet and fundamentals (23 results)

Ensign Group shares have cooled slightly after a strong multi year run, which leaves you weighing entry timing more carefully. Is this recent pause enough of a reset, or does patience still look safer on valuation grounds?

Most Popular Narrative: 20.2% Undervalued

On the most followed view, Ensign Group screens as undervalued, with a narrative fair value of $220 against a last close of $175.46. That gap rests on a mix of aging demographics, quality scores and a growing real estate arm rather than just short term share price action.

Ageing demographics and growing post acute care needs are supporting higher patient volumes, which can sustain occupancy and skilled mix levels across Ensign Group facilities and influence long term revenue growth and earnings.

See why 1 investors see Ensign Group as 20% undervalued.

Result: Fair Value of $220 (UNDERVALUED)

Still, the Ensign Group story can break if Medicare or Medicaid funding tightens, or if the recent wave of low occupancy acquisitions takes longer to turn.

Find out about the key risks to this Ensign Group narrative.

Another Take On Ensign Group’s Valuation

That $220 fair value tag for Ensign Group sits alongside a less forgiving message from the market’s own yardstick. The stock trades on a P/E of 26.8x, compared with a fair ratio of 26.3x, the US Healthcare sector at 24.2x and peers at 15.1x.

This richer multiple hints at less room for error if growth or margins undershoot expectations. If the market leans back toward that fair ratio, how comfortable are you with the downside that implies on a slow news day?

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:ENSG P/E Ratio as at Sep 2026
NasdaqGS:ENSG P/E Ratio as at Sep 2026

Next Steps

Sentiment around Ensign Group is mixed enough that waiting for clarity can feel comfortable, yet momentum can shift before investors react. If you want to see what is driving optimism in the data, take a closer look at the 4 key rewards.

Looking for more Ensign Group style investment ideas?

If you want to keep sharpening your edge beyond Ensign Group, use the Simply Wall St Screener to spot fresh opportunities before the crowd catches on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.